TCL Archive In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas February 3, 1984
TCL Archive Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter October 15, 1976
TCL Archive Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.” December 16, 2005
TCL Archive Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting June 20, 1986
